Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (32)

2024

  1. The Role of Extracellular Vesicles in Metabolic Diseases

    Biomedicines, Vol. 12, Núm. 5

2023

  1. Additional file 1 of P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

    figshare

  2. Additional file 1 of P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

    figshare

2022

  1. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma

    Matrix Biology, Vol. 111, pp. 207-225

  2. Editorial: Molecular Mechanisms of Autophagy in Cancer

    Frontiers in Cell and Developmental Biology

  3. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  4. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

  5. Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

    Cancers, Vol. 14, Núm. 10

  6. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells

    International journal of molecular sciences, Vol. 23, Núm. 18

2021

  1. Cancer Treatment: Preclinical & Clinical

    Journal of the National Cancer Institute - Monographs, Vol. 2021, Núm. 58, pp. 107-113

  2. Combining low-density cell culture, single-cell tracking, and patch-clamp to monitor the behavior of postnatal murine cerebellar neural stem cells

    STAR Protocols, Vol. 2, Núm. 4

  3. Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1β upregulation

    Cancer Letters, Vol. 521, pp. 14-28

  4. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21

2020

  1. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  2. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells

    Theranostics, Vol. 10, Núm. 11, pp. 5120-5136

  3. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

  4. Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors

    ACS Medicinal Chemistry Letters, Vol. 11, Núm. 11, pp. 2221-2226

2019

  1. Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1

    Journal of Cell Science, Vol. 132, Núm. 20

  2. Phosphorylation of FOXO proteins as a key mechanism to regulate their activity

    Methods in Molecular Biology (Humana Press Inc.), pp. 51-59

2018

  1. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

    Biochemical Pharmacology, Vol. 157, pp. 275-284